Open AccessA comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia
Author(s) -
Nobuyuki Hayakawa,
Yuji Nakamoto,
Kensuke Kurihara,
Akihiro Yasoda,
Naotetsu Kanamoto,
Masako Miura,
Nobuya Inagaki,
Kaori Togashi
Publication year - 2015
Publication title -
nuclear medicine communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.489
H-Index - 73
eISSN - 1473-5628
pISSN - 0143-3636
DOI - 10.1097/mnm.0000000000000216
Subject(s) - medicine , hyperparathyroidism , nuclear medicine , lesion , adenoma , hyperplasia , parathyroid hormone , radiology , pet ct , parathyroid neoplasm , primary hyperparathyroidism , parathyroid adenoma , technetium tc 99m sestamibi , positron emission tomography , scintigraphy , pathology , calcium
The purpose of this study was to compare the sensitivity of single-photon emission computed tomography/computed tomography (SPECT/CT) using 99mTc-sestamibi (MIBI) with that of PET/CT using 11C-methionine (MET) for localization of parathyroid adenomas/hyperplasia in primary hyperparathyroidism.